Incozen Therapeutics Pvt. Ltd.;Rhizen Pharmaceuticals SA
发明人:
Meyyappan Muthuppalaniappan,Srikant Viswanadha,Govindarajulu Babu,Swaroop K. Vakkalanka
申请号：
US16109422
公开号：
US20190218211A1
申请日:
2018.08.22
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present invention provides, inter alia, compounds of formula I as protein kinase modulators, methods of preparing them, pharmaceutical compositions containing them and methods of treatment, prevention and/or amelioration of kinase mediated diseases or disorders with them.
